Advertisements



Innate Pharma reports first half 2019 financial results and business update

INNATE PHARMA REPORTS FI.....»»

Category: earningsSource: benzingaSep 13th, 2019

ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019

Conference call and webcast on Wednesday, September 18at 2:30 pm CET/8:30 am EDT TRYbeCA1, Phase 3 trial for eryaspase in second line pancr.....»»

Category: earningsSource: benzingaSep 17th, 2019

Kitov Pharma Reports Year End 2018 Financial Results and Provides Business Update

TEL AVIV, Israel, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Kitov Pharma (NASDAQ/TASE: KTOV), an innovative pharmaceutical company, today reported its unaudited financial results for the year ended December 31, 2018 and provided a business update. Highligh.....»»

Category: earningsSource: benzingaFeb 7th, 2019

Quantum Genomics Reports First Half 2019 Financial Results and Provides Corporate Update

Arterial hypertension: preparing for the pivotal Phase III study of firibastat in patients with re.....»»

Category: earningsSource: benzingaOct 3rd, 2019

CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update

CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaSep 26th, 2019

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update.....»»

Category: earningsSource: benzingaSep 19th, 2019

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update

InMed Pharmaceuticals Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results and Provides R&D and Business Update.....»»

Category: earningsSource: benzingaSep 19th, 2019

FuelCell Energy Reports Third Quarter Fiscal 2019 Financial Results and Business Update

DANBURY, Conn., Sept. 09, 2019 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (the "Company") (NASDAQ:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of ene.....»»

Category: earningsSource: benzingaSep 9th, 2019

MDxHealth Reports Half Year 2019 Financial Results and Strategic Update

Conference call with Q&A today at 11:00 CEST / 10:00 BST, details provided below IRVINE, CA, and HERSTAL, BELGIUM– August 29, 2019 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage inn.....»»

Category: earningsSource: benzingaAug 29th, 2019

NuCana Reports Second Quarter 2019 Financial Results and Provides Business Update

Numerous Clinical Data Announcements.....»»

Category: earningsSource: benzingaAug 21st, 2019

Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update

RUTHERFORD, N.J., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (NASDAQ:CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic, .....»»

Category: earningsSource: benzingaAug 20th, 2019

Stealth BioTherapeutics Reports First Half 2019 Financial Results And Recent Business Highlights

BOSTON, Aug. 14, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology co.....»»

Category: earningsSource: benzingaAug 14th, 2019

Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Completed enrollment of the dose expansion cohort in the Phase 1b/2 CLASSICAL-Lung study in non-small cell lung cancer; primary completion expected in the second half of 2019 Presented interim data from CLASSICAL-Lung study.....»»

Category: earningsSource: benzingaAug 14th, 2019

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019

VANCOUVER and HOUSTON, Aug. 14, 2019 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate ca.....»»

Category: earningsSource: benzingaAug 14th, 2019

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2019

VANCOUVER and HOUSTON, Aug. 14, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (TSXV:EPI, NASDAQ:EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a c.....»»

Category: earningsSource: benzingaAug 14th, 2019

Phio Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update

Phio Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update.....»»

Category: earningsSource: benzingaAug 12th, 2019

Entasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update

WALTHAM, Mass., Aug. 12, 2019 .....»»

Category: earningsSource: benzingaAug 12th, 2019

Galectin Therapeutics Reports Q2 2019 Financial Results and Provides Business Update

NORCROSS, Ga., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today rep.....»»

Category: earningsSource: benzingaAug 9th, 2019

Bellerophon Provides Business Update and Reports Second Quarter 2019 Financial Results

WARREN, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or t.....»»

Category: earningsSource: benzingaAug 8th, 2019

UPDATE - Lightbridge Reports Financial Results for the Second Quarter of 2019 and Provides Business Update on Enfission and Other Developments

UPDATE - Lightbridge Reports Financial Results for the Second Quarter of 2019 and Provides Business Update on Enfission and Other Developments.....»»

Category: earningsSource: benzingaAug 7th, 2019

Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Update

Phase 2 cystic fibrosis clinical trial IND is open in the U.S., protocol endorsed by the Cystic Fibrosis Foundation (CFF) Initiated a Phase 2 clinical tri.....»»

Category: earningsSource: benzingaAug 7th, 2019